Vaccination

The company expects to file for FDA authorization for the 12-17 year old population in June.

Early data suggests vaccines are effective against B.1.617.2 variant first discovered in India.

Vaccinated individuals no longer need to wear masks indoors in accordance with CDC guidance.

More than 3000 people per day in India have died of COVID-19 since April 28.

The companies announce plans to submit a Biologics License Agreement for the mRNA-based vaccine.

Nearly a third of the US population has been fully vaccinated.

New data affirms a low rate of hepatitis B vaccination responsiveness among patients with hepatitis B core antibodies.

The US will send unused vaccines to India to help combat the growing pandemic.

Dr. Anthony Fauci believes the Johnson & Johnson vaccine pause will soon end.

A thrombosis expert details cerebral venous thrombosis, the side effect reported in a half-dozen women administered the Johnson & Johnson vaccine.

FDA, CDC recommended halting use of the one-shot vaccine at all federal sites.

Cases continue to surge across the globe in several countries including India and Pakistan.

Outbreaks continue around the world, including over 100,000 daily cases reported in India.

The companies hope the mRNA vaccine will become the first to be granted full FDA approval.

In a 4000 person study, investigators find vaccinated individuals unlikely to transmit COVID-19.

The US has administered more than 143 million COVID-19 vaccinations.

Some states are seeing troubling COVID-19 trends in recent weeks.

The independent DSMB was concerned over the primary efficacy results shared by AstraZeneca in its interim report Monday morning.

An expert writes on the scope of the next great COVID-19 vaccine challenge: pediatric assessment and administration.

The vaccine was also 100% effective in preventing severe disease.

The US ranks first in the world in vaccines administered.

Guidelines reflect updated guidance from the CDC and FDA.

Vaccinated people may now meet indoors with low-risk unvaccinated individuals without masks or social distancing.

The FDA recently issued the third EUA for a COVID-19 vaccine in the US.

All patients in the study who tested positive for COVID-19 suffered from mild or moderate symptoms.